Document Detail


Effectiveness of lanthanum carbonate treatment used in combination with other phosphate binders in peritoneal dialysis patients.
MedLine Citation:
PMID:  22892485     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Objective Phosphate binders are used in the treatment of hyperphosphatemia in peritoneal dialysis (PD) patients. An ideal phosphate binder for long-term use must be effective with little or no side effects. We evaluated the long-term efficacy and side effects of lanthanum carbonate (LaC) used in combination with other phosphate binders in PD patients. Patients The subjects of this retrospective study were 30 PD patients who received LaC at Kyushu University. The effect of LaC on various biochemical parameters (serum phosphate, calcium and parathyroid hormone), daily dose of other phosphate binders, gastrointestinal side effects, and nutritional status were determined during the 24-week treatment. We also evaluated the rate of achievement of the Japanese Society of Dialysis Treatment guidelines for secondary hyperparathyroidism and used multivariate analysis to determine the factors associated with the efficacy of LaC. Results LaC (960±412 mg/day) reduced serum phosphate from 6.2 to 5.3 mg/dL. The rate of achievement of the guideline target improved after 24 weeks of LaC treatment. The dose of other phosphate binders and dialysis volume remained unchanged during the treatment. Although 53% of patients experienced at least one gastrointestinal side effect, LaC treatment did not affect the nutritional status, and none of the patients discontinued LaC. Multivariate analysis identified low stature, old age and high baseline total creatinine clearance as significant factors that determine the effectiveness of LaC in PD patients. Conclusion Low dose LaC treatment used in combination with other phosphate binders improved serum phosphate control with tolerable gastrointestinal symptoms in PD patients.
Authors:
Shunsuke Yamada; Hisako Yoshida; Masatomo Taniguchi; Shigeru Tanaka; Masahiro Eriguchi; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono
Related Documents :
6414355 - Clomiphene-responsive hypogonadism in sickle cell anemia.
10849385 - Alloimmunization in chinese with warm autoimmune haemolytic anaemia - incidence and cha...
3408135 - Elective splenectomy in haematological disorders.
8200005 - A review of 76 patients with myelodysplastic syndromes treated with danazol.
21155755 - Marked differences in betapapillomavirus dna and antibody prevalence between psoriasis ...
6680195 - Suicide after unilateral ect in a patient previously responsive to bilateral ect.
Publication Detail:
Type:  Journal Article     Date:  2012-08-15
Journal Detail:
Title:  Internal medicine (Tokyo, Japan)     Volume:  51     ISSN:  1349-7235     ISO Abbreviation:  Intern. Med.     Publication Date:  2012  
Date Detail:
Created Date:  2012-08-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9204241     Medline TA:  Intern Med     Country:  Japan    
Other Details:
Languages:  eng     Pagination:  2097-104     Citation Subset:  IM    
Affiliation:
Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of Olmesartan, an Angiotensin II Receptor Blocker, on Peripheral Insulin Sensitivity in Japa...
Next Document:  Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation bas...